Sarcoid Uveitis
Showing 26 - 50 of 323
Uveitis, Posterior Trial in United States (Fluocinolone Acetonide Intravitreal Implant 0.18 mg)
Recruiting
- Uveitis, Posterior
- Fluocinolone Acetonide Intravitreal Implant 0.18 mg
-
Phoenix, Arizona
- +16 more
Aug 18, 2022
Noninfectious Uveitis Trial in Worldwide (Filgotinib, Placebo to match filgotinib, Prednisone)
Anterior Chamber Inflammation by Optical Coherence Tomography
Recruiting
- Uveitis
-
Cleveland, OhioCole Eye Institute
Apr 27, 2022
Uveitis, Cystoid Macular Edema Trial in Winston-Salem (Pegaptanib)
Completed
- Uveitis
- Cystoid Macular Edema
-
Winston-Salem, North CarolinaWake Forest University Eye Center
Mar 7, 2022
Uveitis Trial in United Kingdom
Recruiting
- Uveitis
-
Belfast, United Kingdom
- +30 more
May 19, 2022
Methotrexate and Azathioprine as Background Treatment for
Not yet recruiting
- Uveitis
-
Brest, FranceCHU de Brest
May 10, 2022
Uveitis, Adalimumab Trial in Guangzhou (reduction or discontinuation of Adalimumab)
Recruiting
- Uveitis
- Adalimumab
- reduction or discontinuation of Adalimumab
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Dec 9, 2021
Uveitis Trial in Miami (Norflo Oro, Placebo for Norflo Oro)
Completed
- Uveitis
- Norflo Oro
- Placebo for Norflo Oro
-
Miami, FloridaBascom Palmer Eye Institute
Mar 25, 2022
Uveitis Trial in United States (Izokibep, Prednisone/Prednisolone)
Active, not recruiting
- Uveitis
-
Los Angeles, California
- +3 more
Jul 18, 2022
Pathophysiology of Non-infectious Active Uveitis
Recruiting
- Non-Infectious Active Uveitis
- s-CD95-L
-
Bordeaux, FranceCHU Bordeaux
Apr 11, 2022
Tuberculous Uveitis Trial in Jakarta Pusat (Anti Tuberculosis Drug, Prednisone tablet)
Enrolling by invitation
- Tuberculous Uveitis
- Anti Tuberculosis Drug
- Prednisone tablet
-
Jakarta Pusat, DKI Jakarta, IndonesiaCipto Mangunkusumo National Central General Hospital
Sep 12, 2021
Uveitis Trial in Worldwide (Adalimumab (ADA), Conventional immunosuppression (CON))
Recruiting
- Uveitis
- Adalimumab (ADA)
- Conventional immunosuppression (CON)
-
Los Angeles, California
- +27 more
Jun 16, 2022
Uveitis, Cataract, Inflammation Trial in Mölndal (Hydrophobic IOL: Vivinex (HOYA), Hydrophilic IOL: INCISE (Bausch+Lomb))
Active, not recruiting
- Uveitis
- +3 more
- Hydrophobic IOL: Vivinex (HOYA)
- Hydrophilic IOL: INCISE (Bausch+Lomb)
-
Mölndal, SwedenVastra Gotaland Region, Sahlgrenska University Hospital, Departm
Apr 26, 2022
Juvenile Idiopathic Arthritis Trial in United States (Abatacept Injection, Usual Care)
Recruiting
- Juvenile Idiopathic Arthritis
- Abatacept Injection
- Usual Care
-
Birmingham, Alabama
- +25 more
Aug 16, 2022
Uveitis Related Cystoid Macular Edema, Cystoid Macular Edema, Postoperative Trial (OCS-01)
Not yet recruiting
- Uveitis Related Cystoid Macular Edema
- Cystoid Macular Edema, Postoperative
- (no location specified)
Nov 1, 2022
Objective Choroidal Thickness Measurements in Uveitis
Active, not recruiting
- Uveitis
-
Wrocław, PolandDepartment of Ophthalmology
Mar 27, 2022
Chinese Spondyloarthritis Inception Cohort (CESPIC)
Not yet recruiting
- Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA)
- +6 more
- (no location specified)
Jul 25, 2023
Behçet Disease Trial in Paris (Subcutaneous Ustekinumab)
Completed
- Behçet Disease
- Subcutaneous Ustekinumab
-
Paris, FranceHôpital Cochin, Department of Internal Medicine, National Refere
Nov 19, 2021
Imaging of Uveitis Patients Receiving Injectable Fluocinolone
Recruiting
- Uveitis
- Fluocinolone Acetonide
-
Cleveland, OhioCole Eye Institute Cleveland Clinic Foundation
Apr 27, 2022
ACE and HLA Genotypes Predict Severity and Disease Progression
Recruiting
- Sarcoidosis
-
Aarhus N, DenmarkAarhus University Hospital. Dep. of Respiatory Diseases and Alle
Sep 28, 2021